These findings lead the authors to hypothesize that the SOD-catalase mimetic could be used as a potential therapy for different neurological diseases related to oxidative stress such as Alzheimer's disease and Parkinson's disease [149]. This evidence concerns the gene CAT and early-onset autosomal dominant Alzheimer disease.